Market Cap 40.79M
Revenue (ttm) 0.00
Net Income (ttm) -7.87M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 14,800
Avg Vol 107,976
Day's Range N/A - N/A
Shares Out 8.87M
Stochastic %K 13%
Beta 0.30
Analysts Strong Sell
Price Target $11.00

Company Profile

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9349 4906
Fax: 61 3 9349 4906
Address:
350 Collins Street, Suite 4 Level 14, Melbourne, Australia
stckmuncher
stckmuncher Oct. 25 at 1:11 AM
$ATHE Literally on a plane from DFW to DTW as we speak and folks sitting behind me are talking ATHE. Big things coming!
0 · Reply
stckmuncher
stckmuncher Oct. 25 at 1:09 AM
$ATHE 🚀
0 · Reply
stckmuncher
stckmuncher Oct. 25 at 1:09 AM
$ATHE 🤠
0 · Reply
stckmuncher
stckmuncher Oct. 25 at 1:09 AM
$ATHE 😀
0 · Reply
My_Lai_1968
My_Lai_1968 Oct. 24 at 5:36 AM
$ATHE I was totally confined to a hospital for the first 7 years of my life after accidentally swallowing a harmonica (most likely before I was one year old). Nobody knew until I began coughing badly and a slew of melodies loudly resonated in my throat. I still vividly recall the radiologist telling a nurse that "ATHE is a garbage stock". I'm not sure exactly why he thought that but I did see them both walk to the cafeteria together.
1 · Reply
Botmax
Botmax Oct. 22 at 11:55 PM
$ATHE Ok I have commented on a couple of posts but time to put this Resolution 7 to rest. See below this is from the AGM notice only recently of another Australian biotech DXB. I have been trading investing on the ASX for over 15 years. I am yet to see a single AGM notice in my time for a small cap that doesn't have this resolution. Literally copy and paste for all of them. Doesn't mean they will use it. Its like having a credit card that you don't necessarily need but its nice to have in the back pocket in case of emergency. That's all it is nothing to explain.
4 · Reply
GA09
GA09 Oct. 22 at 7:24 PM
$ATHE CEO will need to explain Resolution 7 because it is confusing. CEO stated he did not favor a dilution but instead would focus on identifying a strategic partner (or a buy-out). So Resolution 7 is confusing and concerning.
2 · Reply
motherlandreturns
motherlandreturns Oct. 22 at 12:51 PM
$ATHE so is this common when trying to find a partner or acquirer? Does this mean they can issue 10% more stock contributing to dilution?
1 · Reply
chrikub
chrikub Oct. 22 at 12:38 AM
$ATHE https://www.neurologylive.com/view/multiple-system-atrophy-phase-2-findings-reinforce-ath434-disease-modifying-potential
0 · Reply
Double__Down
Double__Down Oct. 22 at 12:31 AM
$ATHE are we being diluted again?
2 · Reply
Latest News on ATHE
Alterity Therapeutics to Present at the Biotech Showcase

Sep 2, 2025, 7:25 AM EDT - 7 weeks ago

Alterity Therapeutics to Present at the Biotech Showcase


Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Jul 30, 2025, 7:25 AM EDT - 3 months ago

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report


Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

Apr 30, 2025, 7:35 AM EDT - 6 months ago

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report


Alterity Therapeutics Raises A$40.0 million in Placement

Feb 10, 2025, 7:25 AM EST - 9 months ago

Alterity Therapeutics Raises A$40.0 million in Placement


Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Jan 24, 2025, 7:35 AM EST - 9 months ago

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report


Appendix 4C – Q1 FY25 Quarterly Cash Flow Report

Oct 31, 2024, 7:35 AM EDT - 1 year ago

Appendix 4C – Q1 FY25 Quarterly Cash Flow Report


Appendix 4C – Q4 FY24 Quarterly Cash Flow Report

Jul 31, 2024, 7:35 AM EDT - 1 year ago

Appendix 4C – Q4 FY24 Quarterly Cash Flow Report


Alterity Therapeutics to Present at MST Financial Webinar

Jul 24, 2024, 7:35 AM EDT - 1 year ago

Alterity Therapeutics to Present at MST Financial Webinar


Appendix 4C – Q3 FY24 Quarterly Cash Flow Report

Apr 30, 2024, 7:25 AM EDT - 1 year ago

Appendix 4C – Q3 FY24 Quarterly Cash Flow Report


stckmuncher
stckmuncher Oct. 25 at 1:11 AM
$ATHE Literally on a plane from DFW to DTW as we speak and folks sitting behind me are talking ATHE. Big things coming!
0 · Reply
stckmuncher
stckmuncher Oct. 25 at 1:09 AM
$ATHE 🚀
0 · Reply
stckmuncher
stckmuncher Oct. 25 at 1:09 AM
$ATHE 🤠
0 · Reply
stckmuncher
stckmuncher Oct. 25 at 1:09 AM
$ATHE 😀
0 · Reply
My_Lai_1968
My_Lai_1968 Oct. 24 at 5:36 AM
$ATHE I was totally confined to a hospital for the first 7 years of my life after accidentally swallowing a harmonica (most likely before I was one year old). Nobody knew until I began coughing badly and a slew of melodies loudly resonated in my throat. I still vividly recall the radiologist telling a nurse that "ATHE is a garbage stock". I'm not sure exactly why he thought that but I did see them both walk to the cafeteria together.
1 · Reply
Botmax
Botmax Oct. 22 at 11:55 PM
$ATHE Ok I have commented on a couple of posts but time to put this Resolution 7 to rest. See below this is from the AGM notice only recently of another Australian biotech DXB. I have been trading investing on the ASX for over 15 years. I am yet to see a single AGM notice in my time for a small cap that doesn't have this resolution. Literally copy and paste for all of them. Doesn't mean they will use it. Its like having a credit card that you don't necessarily need but its nice to have in the back pocket in case of emergency. That's all it is nothing to explain.
4 · Reply
GA09
GA09 Oct. 22 at 7:24 PM
$ATHE CEO will need to explain Resolution 7 because it is confusing. CEO stated he did not favor a dilution but instead would focus on identifying a strategic partner (or a buy-out). So Resolution 7 is confusing and concerning.
2 · Reply
motherlandreturns
motherlandreturns Oct. 22 at 12:51 PM
$ATHE so is this common when trying to find a partner or acquirer? Does this mean they can issue 10% more stock contributing to dilution?
1 · Reply
chrikub
chrikub Oct. 22 at 12:38 AM
$ATHE https://www.neurologylive.com/view/multiple-system-atrophy-phase-2-findings-reinforce-ath434-disease-modifying-potential
0 · Reply
Double__Down
Double__Down Oct. 22 at 12:31 AM
$ATHE are we being diluted again?
2 · Reply
GA09
GA09 Oct. 21 at 9:39 PM
$ATHE Interesting clause, "any proportional takeover bids"...
1 · Reply
yft212
yft212 Oct. 21 at 3:29 PM
$GLSI $ATHE $MNKD $SNWV $MLTX Maybe we some mergers or buyouts this year. https://www.fiercepharma.com/manufacturing/merck-grows-again-virginia-3b-small-molecule-drug-plant-500-hires
0 · Reply
Nimmer1
Nimmer1 Oct. 21 at 8:20 AM
$ATHE Today Alterithy announced their agenda for their General annual meeting. Interesting enough, they have a long proposal regarding the handling of a coming take over and how that should be handled ?? Why would you prepare for that ?🙂
1 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 19 at 4:23 PM
Watch VRME possible super run incoming VRME has a rare “floor + optional upside” setup. Strong cash reserves, improving cash flow, tight structure and a golden cross brewing. When volume steps in, this could stretch beyond typical penny stock ranges. $GLMD $ATHE $ACHL $CRVS
1 · Reply
BrokersNY
BrokersNY Oct. 17 at 12:54 PM
$ATHE get ready for a flight soon
0 · Reply
Double__Down
Double__Down Oct. 17 at 3:12 AM
$ATHE slowly continue to accumulate at these levels. Any thoughts on what the floor is here? Will there be another pull back or only up from here?
3 · Reply
stckmuncher
stckmuncher Oct. 16 at 11:41 PM
$ATHE Why would you not accumulate here? Folks still selling like crazy…
0 · Reply
DegenWizard
DegenWizard Oct. 16 at 3:36 PM
$ATHE still slowly climbing. Large purchases at market price driving a slow up trend. Extremely low volume. Minimal sales. Pretty cool to see.
1 · Reply
stckmuncher
stckmuncher Oct. 16 at 12:53 AM
$ATHE YE PEAK PRICE PREDICTION??? I will go first…$367 a share.
2 · Reply
stckmuncher
stckmuncher Oct. 16 at 12:43 AM
$ATHE BUY AND HOLD FOLKS…
0 · Reply
jOm_50Root
jOm_50Root Oct. 15 at 5:51 PM
$ATHE PT anchoring is a psychological cheat code. Print 14 often enough and risk desks reference it. With spot sub 2, R R screens asymmetric. A one unit risk to prior swing low can target 3 to 4 units toward 3.5 then 5. Execution is about phases, not hero entries. 💎
0 · Reply
motherlandreturns
motherlandreturns Oct. 15 at 4:55 PM
$ATHE Should have bought more when this broke below 4 a few weeks back,
0 · Reply